- Home
- PNR vs HOLX Comparison
PNR vs HOLX Comparison
Compare PNR & HOLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PNR | HOLX |
|---|---|---|
| Founded | 1966 | 1985 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medical Electronics |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.7B | 16.6B |
| IPO Year | 2003 | 1995 |
Fundamental Metrics
Financial Performance| Metric | PNR | HOLX |
|---|---|---|
| Price | $94.97 | $75.62 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 14 | 13 |
| Target Price | ★ $116.62 | $77.89 |
| AVG Volume (30 Days) | 1.6M | ★ 2.1M |
| Earning Date | 05-06-2026 | 04-27-2026 |
| Dividend Yield | ★ 1.11% | N/A |
| EPS Growth | ★ 5.88 | N/A |
| EPS | ★ 3.96 | 0.79 |
| Revenue | N/A | ★ $4,100,500,000.00 |
| Revenue This Year | $4.21 | $4.74 |
| Revenue Next Year | $4.60 | $5.03 |
| P/E Ratio | ★ $24.47 | $95.77 |
| Revenue Growth | N/A | ★ 1.74 |
| 52 Week Low | $74.25 | $51.90 |
| 52 Week High | $113.95 | $75.69 |
Technical Indicators
Market Signals| Indicator | PNR | HOLX |
|---|---|---|
| Relative Strength Index (RSI) | 35.38 | 65.86 |
| Support Level | $92.92 | $74.53 |
| Resistance Level | $102.32 | N/A |
| Average True Range (ATR) | 2.46 | 0.22 |
| MACD | -0.39 | 0.04 |
| Stochastic Oscillator | 9.19 | 91.45 |
Price Performance
Historical ComparisonAbout PNR Pentair plc.
Pentair is a global leader in the water treatment industry, with 10,000 employees and a presence in 25 countries. Its business is organized into three segments: pool, water technologies, and flow. The company offers a wide range of water solutions, including energy-efficient swimming pool equipment, filtration solutions, and commercial and industrial pumps. Pentair generated approximately $4.2 billion in revenue in 2025.
About HOLX Hologic Inc.
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.